Skip to main content
BGI Genomics Co., Ltd. logo

BGI Genomics Co., Ltd. — Investor Relations & Filings

Ticker · 300676 ISIN · CNE100003449 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 1,656 across all filing types
Latest filing 2017-08-29 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300676

About BGI Genomics Co., Ltd.

https://www.bgi.com

BGI Genomics Co., Ltd. is a leading provider of integrated solutions for precision medicine, specializing in genomic sequencing and proteomic services. The company offers a comprehensive portfolio of clinical diagnostics and research services across various fields, including reproductive health, oncology, and infectious diseases. Key products include non-invasive prenatal testing, hereditary cancer screening, and pathogen identification tools. Leveraging proprietary DNBseq sequencing technology, BGI Genomics provides high-throughput, cost-effective genomic data analysis to healthcare providers, research institutions, and pharmaceutical companies worldwide. The organization focuses on advancing personalized medicine through large-scale genomic research and the development of innovative diagnostic applications, aiming to improve health outcomes by making advanced genetic insights accessible to a global population.

Recent filings

Filing Released Lang Actions
第一届董事会第十四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 14th meeting of the first board of directors of Shenzhen BGI Genomics Co., Ltd. It includes voting results on various corporate governance matters such as approval of the 2017 semi-annual report, changes in company type and registered capital, amendments to company bylaws, use of raised funds, accounting policy changes, and other governance-related policies. The document references the 2017 semi-annual report but does not contain the report itself; rather, it states that the report is available on the designated disclosure media. The document also includes procedural details about the board meeting and the resolutions passed, which are typical of a Board/Management Information announcement. It is not a full financial report (like an Annual or Interim Report), nor is it a simple announcement of report publication. Therefore, the appropriate classification is Board/Management Information (MANG). The document length (6597 characters) supports it being a substantive announcement rather than a brief notice.
2017-08-29 Chinese
2017年半年度报告披露提示性公告
Report Publication Announcement Classification · 100% confidence The document is a short announcement (447 characters) from Shenzhen BGI Genomics Co., Ltd. It states that the company's 2017 semi-annual report (half-year report) and its summary have been approved and published on the official disclosure website. The text does not contain the actual financial data or the full report itself, but rather informs investors about the availability of the report elsewhere. According to the 'MENU VS MEAL' rule, such a brief notice that a report has been published and is available online is classified as a Report Publication Announcement (RPA), not the report itself (which would be an Interim/Quarterly Report IR).
2017-08-29 Chinese
内部审计工作制度（2017年8月）
Governance Information Classification · 95% confidence The document is titled "深圳华大基因股份有限公司 内部审计工作制度" which translates to "Internal Audit Work System of Shenzhen BGI Genomics Co., Ltd." It is a detailed internal audit policy document approved by the company's board of directors. The content covers the principles, organization, responsibilities, procedures, scope, and management of the internal audit function within the company. It references internal control, audit committee, audit plans, audit reports, and compliance with laws and regulations. There is no indication that this is a financial report like an annual or interim report, nor is it an announcement or a transcript. It is a governance-related document detailing internal audit policies and procedures, which falls under governance information. Therefore, the appropriate classification is Governance Information (CGR). The document length (over 10,000 characters) and detailed content confirm it is not a mere announcement or certification but a substantive governance document.
2017-08-29 Chinese
关联交易管理制度（2017年8月）
Governance Information Classification · 95% confidence The document is titled "深圳华大基因股份有限公司关联交易管理制度" which translates to "Shenzhen BGI Genomics Co., Ltd. Related Party Transaction Management System." It is a detailed internal policy document outlining the principles, definitions, procedures, and disclosure requirements for related party transactions within the company. It includes references to company law, securities law, board and shareholder meeting approvals, and disclosure obligations. The document is a governance-related internal regulation rather than a financial report, announcement, or external filing. It does not contain financial statements, earnings data, or audit results. It is not a report of voting results, nor a call transcript or capital update. It fits best under Governance Information (CGR) as it details the company's internal rules and governance practices regarding related party transactions.
2017-08-29 Chinese
防止控股股东及其关联方资金占用专项制度（2017年8月）
Governance Information Classification · 95% confidence The document is titled as a special system to prevent the controlling shareholder and its related parties from occupying company funds. It contains detailed internal governance rules, principles, responsibilities, and penalties related to controlling shareholder behavior and fund management. There are no financial statements, no earnings data, no audit opinions, no voting results, no announcements of report publications, or any other typical financial report content. The document is a governance-related policy document focusing on internal control and shareholder conduct. It aligns with Governance Information (CGR) as it details company internal rules, board responsibilities, and governance practices to prevent fund misuse by controlling shareholders.
2017-08-29 Chinese
独立董事年报工作制度（2017年8月）
Governance Information Classification · 95% confidence The document is titled '独立董事年报工作制度' which translates to 'Independent Directors Annual Report Work System'. It outlines the responsibilities and procedures for independent directors in relation to the company's annual report preparation and disclosure process. The content focuses on governance mechanisms, internal controls, and the role of independent directors in overseeing the annual report, including interactions with auditors and confidentiality requirements. It does not contain actual financial data or the annual report itself, but rather describes the governance framework and duties related to the annual report. Given the focus on governance and internal rules related to the annual report process, this document fits best under Governance Information (CGR). The document length is short (1267 characters), and it is not an announcement or certification but a policy document.
2017-08-29 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.